Clinical Trial Update: Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor - Optimize Trial [Phase 4]

View source ↗

Summary

Phase 4 trial update on optimizing the duration of clopidogrel therapy after Endeavor stent treatment in coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Cardiovascular Research Center, Brazil | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED